“…For example, gray matter (GM) atrophy of the cerebellum was detected in AD in several neuroimaging studies (Thomann et al, 2008; Bas et al, 2009). In addition, the AD patients exhibited significantly lower cerebral blood flow (CBF; Hauser et al, 2013), abnormal activation during Stroop tests (Kaufmann et al, 2008) and impaired rsFCs of the cerebellum (Wang et al, 2007; Zhang et al, 2014) in several studies. Furthermore, the AD pathological changes have now been revealed in the cerebellum including deposits of amyloid-β plaques, neurofibrillary tangles, increased microglia and so on (Larner, 1997; Ciavardelli et al, 2010; Sepulveda-Falla et al, 2011).…”